IRONWOOD PHARMACEUTICALS, INC. CLASS A
(NASDAQ: IRWD)

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

4.450 s

+0.570 (+14.69%)
Range 3.780 - 5.129   (35.69%)
Open 3.890
Previous Close 3.880
Bid Price 10.730
Bid Volume 8
Ask Price 10.740
Ask Volume 9
Volume 10,928,261
Value -
Remark s
Delayed prices. Updated at 21 Dec 2024 05:00.
Data powered by
View All Events

About IRONWOOD PHARMACEUTICALS INC

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

Loading Chart...

Please login to view stock data and analysis